Neuberger Berman Group
IDNA icon

Neuberger Berman Group’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Neuberger Berman Group’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-34,501
Closed -$1.51M – 1939
2021
Q4 		$1.51M Buy
+34,501
New +$1.63M ﹤0.01% 1251

Other funds holding IDNA

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Neuberger Berman Group's IDNA Position: Q1 2022 in Review

Neuberger Berman Group sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2022, closing a stake of 34,501 shares — an estimated $1.51M sold.

Neuberger Berman Group first reported a position in IDNA in Q4 2021 and held it in 1 quarter. The position peaked at $1.51M in Q4 2021. 86 funds tracked by Wall St. Rank hold IDNA as of Q1 2022.

  • Neuberger Berman Group reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2022 after selling out during the quarter.
  • Neuberger Berman Group sold 34,501 iShares Genomics Immunology and Healthcare ETF shares in Q1 2022, an estimated $1.51M.
  • Neuberger Berman Group first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2021 and held it in 1 quarter.
  • Neuberger Berman Group's iShares Genomics Immunology and Healthcare ETF position peaked at $1.51M in Q4 2021.
  • 86 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2022.

Based on Neuberger Berman Group's 13F filing for Q1 2022, filed 13 May 2022.